Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Hall

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Journal of Colloid and Interface Science|January 17, 2025
Protecting monoclonal antibodies via competitive interfacial adsorption of nonionic surfactantsZeyuan Zhuang, Haoran Wu, Zongyi Li, et al.
ACS Omega|October 14, 2024
Thin Film TaFe, TaCo, and TaNi as Potential Optical Hydrogen Sensing MaterialsLars J Bannenberg, Isa M Veeneman, Folkert I B Straus, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiationJames E Dixon, Disheet A Shah, Catherine Rogers, et al.
ACS Applied Materials & Interfaces|February 16, 2026
Selective Serine Substitutions of Antimicrobial Peptides Reveal Different Mechanistic Actions Toward Gram-Negative BacteriaAnna Stephens, Tianhao Ge, Ke Ding, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Lancet (London, England)|July 19, 2008
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialPaul Emery, Ferdinand C Breedveld, Stephen Hall, et al.
ACR Open Rheumatology|January 17, 2020
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 StudyPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.
RMD Open|September 1, 2018
Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trialPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.
Critical Care Medicine|August 9, 2019
Evaluation and Predictors of Fluid Resuscitation in Patients With Severe Sepsis and Septic ShockHani I Kuttab, Joseph D Lykins, Michelle D Hughes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2023
Developments in understanding early onset Alzheimer's diseasePercy Griffin, Liana Apostolova, Bradford C Dickerson, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Journal of Colloid and Interface Science|January 17, 2025
Protecting monoclonal antibodies via competitive interfacial adsorption of nonionic surfactantsZeyuan Zhuang, Haoran Wu, Zongyi Li, et al.
ACS Omega|October 14, 2024
Thin Film TaFe, TaCo, and TaNi as Potential Optical Hydrogen Sensing MaterialsLars J Bannenberg, Isa M Veeneman, Folkert I B Straus, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiationJames E Dixon, Disheet A Shah, Catherine Rogers, et al.
ACS Applied Materials & Interfaces|February 16, 2026
Selective Serine Substitutions of Antimicrobial Peptides Reveal Different Mechanistic Actions Toward Gram-Negative BacteriaAnna Stephens, Tianhao Ge, Ke Ding, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Lancet (London, England)|July 19, 2008
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialPaul Emery, Ferdinand C Breedveld, Stephen Hall, et al.
ACR Open Rheumatology|January 17, 2020
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 StudyPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.
RMD Open|September 1, 2018
Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trialPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.
Critical Care Medicine|August 9, 2019
Evaluation and Predictors of Fluid Resuscitation in Patients With Severe Sepsis and Septic ShockHani I Kuttab, Joseph D Lykins, Michelle D Hughes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2023
Developments in understanding early onset Alzheimer's diseasePercy Griffin, Liana Apostolova, Bradford C Dickerson, et al.
Pageof 16